-
PublishedMay 18, 2023
FDA advisers back RSV vaccine for pregnant women that protects their newborns
If the FDA ultimately approves the maternal shot, it would mark a second milestone in the decades-long quest to prevent the respiratory syncytial virus.
-
PublishedDecember 5, 2022
Pfizer asks FDA to clear updated COVID shot for kids under 5
Children ages 6 months through 4 years already are supposed to get three extra-small doses of the original Pfizer COVID-19 vaccine.
-
PublishedOctober 21, 2022
Pfizer says COVID-19 vaccine will cost $110-$130 per dose
Still, many people are expected to continue receive it for free once the U.S. government stops buying the shots, the drugmaker says.
-
PublishedOctober 5, 2022
Our View: COVID boosters key to getting through Maine winter
We may or may not be heading for a severe surge. But if we do, the new booster shots will help limit its impact.
-
PublishedSeptember 20, 2022
New York City ending vaccine mandate for private employers on Nov. 1
New York City will lift its private-sector COVID-19 vaccine mandate on Nov. 1 but will continue to require city employees to be vaccinated against the virus.
-
PublishedJune 28, 2022
FDA advisers recommend updating COVID booster shots for fall
They're hoping to better match vaccines to more recent variants of the coronavirus.
-
PublishedJune 23, 2022
Our View: Long-awaited COVID vaccine for young children is finally here
But parents will have to sift though misinformation and take advantage of this opportunity.
-
PublishedJune 14, 2022
FDA advisers consider Moderna’s COVID shots for older kids
If the advisory panel endorses the shot and the FDA agrees, it would become the second option for those children, joining Pfizer's vaccine.
-
PublishedJune 7, 2022
FDA advisers back Novavax COVID-19 shots as new U.S. option
Studies in the U.S., Mexico and Britain found two doses of the vaccine were safe and about 90% effective.
-
PublishedJune 2, 2022
First COVID vaccine shots for kids under 5 possible by June 21
White House COVID-19 coordinator Aashish Jha outlined the administration's planning for the last remaining ineligible age group to get shots.
- 1
- 2
- 3
- …
- 54
- Next Page →
